Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.

BACKGROUND: Bridging therapy with low-molecular-weight heparin is usually recommended in patients who must stop oral anticoagulants before surgical or invasive procedures. To date, there is no universally accepted bridging regimen tailored to the patient's thromboembolic risk. This prospective inception cohort management study was designed to assess the efficacy and safety of an individualized bridging protocol applied to outpatients. METHODS AND RESULTS: Oral anticoagulants were stopped 5 days before the procedure. Low-molecular-weight heparin was started 3 to 4 days before surgery and continued for 6 days after surgery at 70 anti-factor Xa U/kg twice daily in high-thromboembolic-risk pati…

Ricerca sugli outcomes di Orthos: programma residenziale di psicoterapia intensiva per giocatori d'azzardo

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation -a look beyond the excellent results

Challenges in Energy Systems for the Smart- Cities of the Future

In the last years the European Union has actively promoted the renewable energies and the Combined Heat and Power (CHP) also for residential and tertiary buildings. The exploitation of renewable sources and cogeneration seems hampered by the regulatory wall that prohibit for residential, tertiary and commercial buildings the constitution of users clusters. In fact, the unification up to a threshold value of some tens of kVA, at least, can facilitate the installation of renewable energy power plants as solar PV modules or CHP systems (cogeneration) or CCHP systems (tri-generation), overcoming technical and economical barriers and combining several load profiles. The actual distribution syste…

Aspirin for preventing the recurrence of venous thromboembolism